Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Progyny, Inc.
  6. Summary
    PGNY   US74340E1038

PROGYNY, INC.

(PGNY)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/28/2021 07/29/2021 07/30/2021 08/02/2021 08/03/2021 Date
54.44(c) 55.51(c) 55.69(c) 56.07(c) 55.6356 Last
703 414 485 074 495 882 569 530 317 977 Volume
+2.02% +1.97% +0.32% +0.68% -0.77% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 536 M - -
Net income 2021 41,4 M - -
Net cash position 2021 204 M - -
P/E ratio 2021 155x
Yield 2021 -
Sales 2022 776 M - -
Net income 2022 60,3 M - -
Net cash position 2022 275 M - -
P/E ratio 2022 109x
Yield 2022 -
Capitalization 4 964 M 4 964 M -
EV / Sales 2021 8,88x
EV / Sales 2022 6,05x
Nbr of Employees 210
Free-Float 82,9%
More Financials
Company
Progyny Inc is a United States-based fertility benefits management company. The Company specialized in fertility and family building benefits solutions in the United States. The Company offers patients a benefits solution with education and guidance from a patient care advocate and network of fertility specialists. Progyny also aims to reduce healthcare costs for employers through their operations. 
Sector
Managed Healthcare
Calendar
08/05Earnings Release
More about the company
Ratings of Progyny, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about PROGYNY, INC.
08/02GETTING TO KNOW OUR MEDICAL ADVISORY : Dr. Janet Choi
PU
07/22PROGYNY : Announces Details for Its Second Quarter 2021 Results Report
AQ
07/21PROGYNY WEBINAR : Journey to Fatherhood: Same-sex Couples + Single Fathers by Ch..
PU
07/08PROGYNY : Family Building Coverage Changed Our Lives
PU
07/02GETTING TO KNOW OUR MEDICAL ADVISORY : Dr. Jonathan Kort
PU
07/01PROGYNY : How Fertility Benefits Can Attract and Retain Top Talent
PU
07/01PROGYNY WEBINAR : Journey to Fatherhood: Same-sex Couples + Single Fathers by Ch..
PU
06/21PROGYNY : Breaking the Silence and Stigma at Work
PU
06/18GETTING TO KNOW OUR MEDICAL ADVISORY : Dr. Bradford Kolb
PU
06/17PROGYNY : Juneteenth
PU
06/17PROGYNY WEBINAR : The Journey to Fatherhood: Male Infertility 101
PU
06/15PROGYNY : Launches YouTube Channeláto Expand Family Building Education Resources
PU
06/09PROGYNY : The Equitable Fertility and Family Building Checklist
PU
06/04PROGYNY WEBINAR : LGBTQ+ Family Building: Donor 101
PU
06/04Progyny, Inc. to Present at the Goldman Sachs 42nd Annual Global Healthcare C..
GL
More news
News in other languages on PROGYNY, INC.

- No features available -

More news
Analyst Recommendations on PROGYNY, INC.
More recommendations
Chart PROGYNY, INC.
Duration : Period :
Progyny, Inc. Technical Analysis Chart | PGNY | US74340E1038 | MarketScreener
Technical analysis trends PROGYNY, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 56,07 $
Average target price 66,00 $
Spread / Average Target 17,7%
EPS Revisions
Managers and Directors
David J. Schlanger Chief Executive Officer & Director
Peter Anevski President & Chief Operating Officer
Mark Livingston Chief Financial Officer
Beth C. Seidenberg Chairman
Alan B. Copperman Medical Director
Sector and Competitors
1st jan.Capi. (M$)
PROGYNY, INC.32.27%4 964
UNITEDHEALTH GROUP18.50%392 174
ANTHEM, INC.19.60%95 159
CIGNA CORPORATION10.17%78 700
HUMANA INC.3.80%55 203
CENTENE CORPORATION17.12%40 994